Nateglinide HCI EP/USP/JP Cas No: 105816-04-4

Cas No: 105816-04-4

Nateglinide is an oral antihyperglycemic agent used for the treatment of non-insulin-dependent diabetes mellitus (NIDDM). It belongs to the meglitinide class of short-acting insulin secretagogues, which act by binding to β cells of the pancreas to stimulate insulin release.Nateglinide is an oral antihyperglycemic agent used for the treatment of non-insulin-dependent diabetes mellitus Nateglinide activity is dependent on the presence functioning β cells and glucose. In contrast to sulfonylurea insulin secretatogogues, nateglinide has no effect on insulin release in the absence of glucose.